Company profile: Bard
1.1 - Company Overview
Company description
- Provider of medical technologies in vascular, urology, oncology, and surgical specialties, including devices for vascular disease (stents, grafts, catheters); urology (Foley catheters, drainage systems); oncology (ports, PICCs, biopsy devices); and surgical procedures (hernia repair and soft tissue reconstruction).
Products and services
- Oncology Products: Delivers clinical-grade products for treatment and management of cancer, including ports, PICCs, and biopsy devices used in oncology care
- Surgical Specialty Products: Engineers surgical-grade instruments and devices used in various surgical procedures, including hernia repair and soft tissue reconstruction
- Urology Products: Produces medical-grade devices for diagnosis and treatment of urological conditions, such as Foley catheters and drainage systems
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bard
Mindray
HQ: United States
Website
- Description: Provider of medical devices, including A8/A9 anesthesia workstations to enhance patient safety and operational efficiency; TE Air handheld ultrasound connecting to mobile devices or the TE X system; BeneVision N-Series patient monitoring integrating FloTrac sensor technology; BC-5390 and BC-3600 hematology analyzers; and inReach refurbished ultrasound, anesthesia, and patient monitoring machines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mindray company profile →
GM Instruments
HQ: United States
Website
- Description: Provider of medical technology instruments focused on flow and pressure measurements, offering product categories in audiometry, nasal congestion measurements, and respiratory flow measurements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GM Instruments company profile →
Boston Scientific
HQ: United States
Website
- Description: Provider of medical technology solutions to improve patient health, including pacemakers and implantable cardioverter defibrillators, the S-ICD System for arrhythmia treatment, TheraSphere Y-90 glass microspheres for liver cancer, coronary stents for percutaneous coronary interventions, and GreenLight laser therapy for benign prostatic hyperplasia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Scientific company profile →
Philips BioTel Care
HQ: United States
Website
- Description: Provider of mobile health technology and services that enable healthcare providers to monitor and diagnose patients, delivering health information to save and improve lives while reducing the cost of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Philips BioTel Care company profile →
Stimdia
HQ: United States
Website
- Description: Provider of neurostimulation-based lung pacing solutions to facilitate weaning from mechanical ventilation, including the pdSTIM System that reconditions the diaphragm by stimulating the phrenic nerves through percutaneously inserted leads. Also conducts clinical studies such as ReInvigorate and the EU PEPNS feasibility study in ICU patients requiring mechanical ventilation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stimdia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bard
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bard
2.2 - Growth funds investing in similar companies to Bard
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bard
4.2 - Public trading comparable groups for Bard
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →